integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
UUDOMEYLXRMHOC-FXHMYPJMSA-N
DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
UUDOMEYLXRMHOC-FXHMYPJMSA-N
CHEBI:88399
0 Reactome links
2 studies
2
Observed studies
2
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
UUDOMEYLXRMHOC-FXHMYPJMSA-N
InChI Key
UUDOMEYLXRMHOC-FXHMYPJMSA-N
IUPAC name
Preferred name
DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
INN name
—
Synonym
DAG(18:1/20:4)
ChEBI
CHEBI:88399
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
Observed in differential profiles
Control_vs_AONFH_Stage_III_IV
Normal_control_no_tumor_vs_FH_deficient_RCC